N-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYLMETHYL]-N-(3-HYDROXYPROPYL)-4-CHLORO-6-(2-METHYLPHENYL)-2-METHYLTHIOPYRIMIDINE-5-CARBOXAMIDE
Compound with spectra: 1 NMR
![N-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYLMETHYL]-N-(3-HYDROXYPROPYL)-4-CHLORO-6-(2-METHYLPHENYL)-2-METHYLTHIOPYRIMIDINE-5-CARBOXAMIDE](/api/compound/7d9ouUOAnUo.png?ph=true&h=300&w=458 "N-[3,5-BIS-(TRIFLUOROMETHYL)-PHENYLMETHYL]-N-(3-HYDROXYPROPYL)-4-CHLORO-6-(2-METHYLPHENYL)-2-METHYLTHIOPYRIMIDINE-5-CARBOXAMIDE")
| SpectraBase Compound ID | 7d9ouUOAnUo |
|---|---|
| InChI | InChI=1S/C25H22ClF6N3O2S/c1-14-6-3-4-7-18(14)20-19(21(26)34-23(33-20)38-2)22(37)35(8-5-9-36)13-15-10-16(24(27,28)29)12-17(11-15)25(30,31)32/h3-4,6-7,10-12,36H,5,8-9,13H2,1-2H3 |
| InChIKey | DBVYZGDPFBZXTA-UHFFFAOYSA-N |
| Mol Weight | 577.97 g/mol |
| Molecular Formula | C25H22ClF6N3O2S |
| Exact Mass | 577.102545 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2,4-Bis(methylsulfanyl)indeno[1,2-d]pyrimidin-5-one
2-(benzylthio)-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one
Dimethyl 4,6-dimethyl-2-[2'-(trifluoromethyl)phenyl]pyridine-3,5-dicarboxylate
1,3-Dimethyl-indeno(J,K)fluorene
4-Acetoxy-2-phenyl-1-[(2'-phenyl-1'-naphthyl)oxy]naphthalene
1H-thieno[2,3-c]pyrazole-5-carboxamide, 3-methyl-N-[5-methyl-1-[(2-methylphenyl)methyl]-1H-pyrazol-3-yl]-1-phenyl-
3,5-bis(difluoromethyl)-1-[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]-4,5-dihydro-1H-pyrazol-5-ol
N-[4-[chloranyl-bis(fluoranyl)methoxy]phenyl]-N-methyl-2-[[4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolin-2-yl]sulfanyl]ethanamide
(6,7-diacetoxy-2-phenyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazol-5-yl)methyl acetate
9-METHYL-7-PHENYL-7,8,9,10-TETRAHYDROPYRIDO[4,3-h]QUINAZOLINE-2,4-DIOL
| Title | Journal or Book | Year |
|---|---|---|
| Process Development and Large-Scale Synthesis of NK1 Antagonist | Chemical and Pharmaceutical Bulletin | 2008 |